Scynexis (SCYX) Invested Capital (2013 - 2023)

Scynexis' (SCYX) quarterly Invested Capital came in at $34.6 million in Q1 2023, up 371.47% on a QoQ basis from $7.3 million in Q3 2018.

Scynexis (SCYX) Invested Capital (2013 - 2023) Analysis & Trends

Scynexis (SCYX) has 5 years of Invested Capital data on file, last reported at $34.6 million in Q1 2023.

Quarterly Invested Capital changed N/A year-over-year to $34.6 million in Q1 2023, while the trailing twelve-month figure through Dec 2023 was $34.6 million (changed N/A YoY) and the FY2017 annual result came in at $4.3 million, changed N/A from the prior year.
Invested Capital grew to $34.6 million in Q1 2023, from $7.3 million in the prior quarter.
In the past five years, Invested Capital ranged from a high of $34.6 million in Q1 2023 to a low of $34.6 million in Q1 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Haleon	44.51 Bn	43.55 Bn	-	9.90 Bn
2	Teva Pharmaceutical Industries	43.52 Bn	39.86 Bn	2.15 Bn	4.50 Bn
3	Zoetis	32.43 Bn	30.75 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn	3.74 Bn
5	United Therapeutics	21.87 Bn	19.21 Bn	683.80 Mn	-
6	Viatris	18.98 Bn	18.09 Bn	1.46 Bn	1.74 Bn
7	Neurocrine Biosciences	15.43 Bn	15.04 Bn	935.80 Mn	-
8	Elanco Animal Health	12.02 Bn	11.49 Bn	798.00 Mn	73.00 Mn
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-	630.00 Mn
10	Scynexis	60.54 Mn	-54.16 Mn	-	-

Download Data